...
首页> 外文期刊>Pakistan journal of medical sciences. >Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in Combination with MTHFR C677T Genetic Polymorphism in gastric cancer
【24h】

Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in Combination with MTHFR C677T Genetic Polymorphism in gastric cancer

机译:胃癌中P16,MGMT和hMLH1基因的异常DNA甲基化与MTHFR C677T遗传多态性结合

获取原文

摘要

Objective: We aimed to explore the association of P16, MGMT and HMLH1 with gastric cancer and their relation with Methylenetetrahydrofolate reductase (MTHFR).Methods: 322 gastric patients who were confirmed with pathological diagnosis were included in our study. Aberrant DNA methylation of P16, MGMT and HMLH1 and polymorphisms of MTHFR C677T and A1298C were detected using PCR-RFLP.Results: The proportions of DNA hypermethylation in P16, MGMT and hMLH1 genes in gastric cancer tissues were 75.2% (242/322), 27.6% (89/322) and 5.3% (17/322), respectively. In the remote normal-appearing tissues, 29.5% (95/322) and 16.1%(52/322) showed hypermethylation in P16 and MGMT genes, respectively. We found a significantly higher proportion of DNA hypermethylation of P16 in patients with N1 TNM stage in cancer tissues and remote normal-appearing tissues (P<0.05). Similarly, we found DNA hypermethylation of MGMT had significantly higher proportion in N1 and M1 TNM stage (P<0.05). Individuals with homozygotes (TT) of MTHFR C677T had significant risk of DNA hypermethylation of MGMT in cancer tissues [OR (95% CI)=4.27(1.76-7.84)], and a significant risk was also found in those carrying MTHFR 677CT/TT genotype [OR (95% CI)= 3.27(1.21-4.77)].Conclusion: We found the aberrant hypermethylation of cancer-related genes, such as P16, MGMT and HMLH1, could be predictive biomarkers for detection of gastric cancer.doi: http://dx.doi.org/10.12669/pjms.296.3711How to cite this:Song B, Ai J, Kong X, Liu D, Li J. Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in Combination with MTHFR C677T Genetic Polymorphism in gastric cancer. Pak J Med Sci 2013;29(6):1338-1343. doi: http://dx.doi.org/10.12669/pjms.296.3711This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:探讨P16,MGMT和HMLH1与胃癌的关系及其与亚甲基四氢叶酸还原酶(MTHFR)的关系。方法:本研究纳入322例经病理证实的胃癌患者。通过PCR-RFLP检测P16,MGMT和HMLH1的异常DNA甲基化以及MTHFR C677T和A1298C的多态性。结果:胃癌组织中P16,MGMT和hMLH1基因的DNA超甲基化比例为75.2%(242/322), 27.6%(89/322)和5.3%(17/322)。在偏远正常组织中,P16和MGMT基因分别有29.5%(95/322)和16.1%(52/322)显示出高甲基化。我们发现在癌组织和远距正常组织中处于N1 TNM分期的患者中,P16的DNA高甲基化比例显着更高(P <0.05)。同样,我们发现MGMT的DNA高甲基化在N1和M1 TNM期显着更高(P <0.05)。具有MTHFR C677T纯合子(TT)的个体在癌症组织中具有MGMT DNA超甲基化的显着风险[OR(95%CI)= 4.27(1.76-7.84)],在携带MTHFR 677CT / TT的患者中也发现了显着风险基因型[OR(95%CI)= 3.27(1.21-4.77)]。结论:我们发现癌症相关基因(如P16,MGMT和HMLH1)的异常甲基化可能是检测胃癌的预测生物标志物。 http://dx.doi.org/10.12669/pjms.296.3711如何引用:宋B,艾J,孔X,刘D,李J.P16,MGMT和hMLH1基因与MTHFR结合的异常DNA甲基化胃癌中的C677T遗传多态性。 Pak J Med Sci 2013; 29(6):1338-1343。 doi:http://dx.doi.org/10.12669/pjms.296.3711这是根据知识共享署名许可(http://creativecommons.org/licenses/by/3.0)条款发布的开放获取文章,允许在任何媒体中无限制地使用,分发和复制,但必须正确引用原始作品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号